Background Herpes simplex virus type 2 (HSV-2) infection is usually tr
ansmitted sexually and can cause recurrent, painful genital ulcers. In
neonates the infection is potentially lethal. We investigated the ser
oprevalence and correlates of HSV-2 infection in the United States and
identified changes in HSV-2 seroprevalence since the late 1970s. Meth
ods Serum samples and questionnaire data were collected during the Nat
ional Health and Nutrition Examination Surveys (NHANES) II (1976 to 19
80) and III (1988 to 1994). HSV-2 antibody was assessed with an immuno
dot assay specific for glycoprotein gG-2 of HSV-2. Results From 1988 t
o 1994, the seroprevalence of HSV-2 in persons 12 years of age or olde
r in the United States was 21.9 percent (95 percent confidence interva
l, 20.2 to 23.6 percent), corresponding to 45 million infected people
in the noninstitutionalized civilian population. The seroprevalence wa
s higher among women (25.6 percent) than men (17.8 percent) and higher
among blacks (45.9 percent) than whites (17.6 percent). Less than 10
percent of all those who were seropositive reported a history of genit
al herpes infection. In a multivariate model, the independent predicto
rs of HSV-2 seropositivity were female sex, black race or Mexican-Amer
ican ethnic background, older age, less education, poverty, cocaine us
e, and a greater lifetime number of sexual partners. As compared with
the period from 1976 to 1980, the age-adjusted seroprevalence of HSV-2
rose 30 percent (95 percent confidence interval, 15.8 to 45.8 percent
). The seroprevalence quintupled among white teenagers and doubled amo
ng whites in their twenties. Among blacks and older whites, the increa
ses were smaller. Conclusions Since the late 1970s, the prevalence of
HSV-2 infection has increased by 30 percent, and HSV-2 is now detectab
le in roughly one of five persons 12 years of age or older nationwide.
Improvements in the prevention of HSV-2 infection are needed, particu
larly since genital ulcers may facilitate the transmission of the huma
n immunodeficiency virus. (C) 1997, Massachusetts Medical Society.